Back to Trades
David Matthew T
Chief Financial OfficerCIK 0001811612
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
David Matthew T, Chief Financial Officer, has filed 2 SEC reports (2026), all concentrated in Actinium Pharmaceuticals, Inc. (ATNM), totaling $243.8K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 16 | ATNM Actinium Pharmaceuticals, Inc. | David Matthew T | Chief Financial Officer | Other | $0 |
| Oct 16 | ATNM Actinium Pharmaceuticals, Inc. | David Matthew T | Chief Financial Officer | Grant | $243.8K |
2 filings